Bone marrow aspirate concentrate, otherwise known as BMAC, is an autologous stem cell therapy procedure used by Dr. Mark Getelman to accelerate the body’s natural healing process. Over the years, more and more patients are utilizing BMAC to help aid in the healing of many orthopedic and sports injuries. Patients suffering from chronic tendon injuries or cartilage injuries in the greater Van Nuys, Thousand Oaks and Los Angeles, California area are encouraged to contact Dr. Getelman to discuss the many benefits of bone marrow aspirate concentrate.
Bone marrow aspirate concentrate (BMAC) is gaining popularity as a safe and potentially effective treatment option for a variety of orthopedic conditions, such as:
- Tendon injuries
- Ligament injuries
- Cartilage injuries
A large portion of the body’s stem cells are found in bone marrow. These stem cells have a natural ability to aid in healing a number of injuries. Bone marrow aspirate concentrate uses a patient’s own ‘pluripotent’ stem cells, also known as autologous stem cells or adult stem cells. Orthopedic specialists offering autologous stem cell therapy can potentially improve healing potential in patients without the ethical concerns and complications of utilizing embryonic stem cells. Patients undergoing BMAC have a reduced rate of infection and other serious complications since they are using their very own stem cells.
The autologous stem cells, or adult stem cells, are extracted from a patient’s body, typically from bone marrow in the pelvis region. Once the bone marrow is harvested, it is circulated in a special machine called a centrifuge. The centrifuge separates the blood into various sections, including pluripotent stem cells, platelets and white blood cells. The combination is then injected into the patient’s damaged tissues to promote regeneration and healing.
BMAC is not for all patients. Dr. Getelman may recommend this treatment to patients who have moderate osteoarthritis where a complete collapse of the joint is not present. BMAC is also recommended for certain ligament and tendon injuries that have not responded to other treatments options.
Patients up to the age of 60 years can typically achieve regeneration using their own pluripotent stem cells through BMAC therapy. Patients over the age of 60 years may develop senescent cells and typically do not achieve the same healing benefits since the body typically loses its ability to regenerate stem cells as it ages. Dr. Getelman will discuss his recommendations for each patient during the consultation.
For more resources on bone marrow aspirate concentrate, or to determine if you are an ideal candidate for BMAC, contact the Van Nuys, Thousand Oaks and Los Angeles, California office of Dr. Mark Getelman.